Hormone Therapy Timing & Heart Risk
study3_post01  |  image: study3_post01_clinical.png
------------------------------------------------------------------------

ON THE IMAGE
10 years — the window in which hormone therapy shows a more favorable cardiovascular profile

CAPTION
The single most consistent theme across the cardiovascular evidence: timing.

This 2026 review synthesizes major randomized trials, national registries and meta-analyses. The pattern that holds across them is that hormone therapy begun within about ten years of menopause carries a different cardiovascular profile than therapy begun well after.

That's a conversation about individual timing and risk — exactly the kind worth having with a clinician.

Questions about what this means for you? Call [Practice Name] at [Phone] or book at [Booking Link].

Educational content, not medical advice — individual results and risks vary.

HASHTAGS
#menopause #womenshealth #hearthealth #hormonetherapy #midlifewomen

SUPPORTING EVIDENCE
Abstract: early initiation of HRT within 10 years of menopause onset consistently demonstrates cardiovascular benefits.
